False Positives in the Early Stages of Drug Discovery
Keywords: 2-amino-3-carbonyl tiophenes; 2-hydroxyphenylhydrazones; ALARM NMR; Acylhydrazides; Azoalkanals; CAC; CHAPS; CLND; Chymotrypsin; Clioquinol; Delavirdine; Enzyme Concentration; Epoxides; Glyburide; HTS; Hydroxyphenilhydrazones; Incubation Effect; Light Scattering; NMR; Nitroalkanes; Oxaprozin; PAINS; Perhaloketones; Plasmon Resonance; SRR (structure-reactivity relationship); Shoichet; Sulfonates; Thioepoxides; WaterLOGSY spectrum; aggregate-based promiscuous inhibitors; allopurinol; angiogenin; b-lactamase; baseline enzyme; chicken DHFR; cysteine proteases; dihydrofolate; drug discovery; hydrogen-deuterium; indiscriminate; mechanism of false-positive inhibition; metalloproteinase; methods for detecting false positives; microsecond; misinformed; more sophisticated; nicardipine; nonleadlike; omeprazole; optical biosensor surface; perplexing; photoactive dyes; prioritization; promiscuous inhibitors; pronounced capillarity; reactive compounds; red-horseradish; stoichiometry; sulfhydryl group; tetraiodophenolphthalein; thiol-reactive
Document Type: Research Article
Publication date: 2010-12-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.